214398-99-9Relevant academic research and scientific papers
Production method of vildagliptin
-
Paragraph 0079-0084; 0096-0099, (2021/10/27)
and Alkali metal bromides are in vildagliptin or a salt thereof. Use of a crystal form, a deuterated substance, a tritium substitute, and a solvate as a catalyst. The vildagliptin product produced by the method is high in purity and low in impurity content, particularly the product quality control of the vildagliptin bulk drug and/or the pharmaceutical preparation is facilitated. Moreover, the reaction condition is mild, operation and control are convenient, the yield is high, the energy consumption is low, the cost is low, and the method is suitable for industrial production and popularization and application.
Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators
Fang, Yuanying,Zhang, Shaokun,Wu, Wenting,Liu, Yanhua,Yang, Juan,Li, Yuyuan,Li, Min,Dong, Huanhuan,Jin, Yi,Liu, Ronghua,Yang, Zunhua
, (2019/11/13)
Based on the approach of merged pharmacophores of GPR119 agonists and DPP-4 inhibitors, a series of tetrahydropyridopyrimidine compounds were designed as dual GPR119 and DPP-4 modulators with hypoglycemic activity. Seven fragments extracted from DPP-4 inhibitors were hybridized with the scaffold of tetrahydropyridopyrimidine. Among them, compound 51 displayed most potent GPR119 agonistic activity (EC50 = 8.7 nM) and good inhibition rate of 74.5% against DPP-4 at 10 μM. Furthermore, the blood glucose AUC0-2h of 51 was reduced to 19.5% in the oral glucose tolerance test (oGTT) at the dose of 30 mg/kg in C57BL/6N mice, which was more potent than that of vildagliptin (16.4%) at the same dose. The docking study of compound 51 with DPP-4 indicated GPR119 agonists could inhibit DPP-4 to serve as dual GPR119 and DPP-4 modulators.
A new uygur geleg [...] ammonium salt impurity and its preparation method
-
Paragraph 0039; 0041; 0043, (2019/05/28)
The invention relates to a new uygur geleg [...] ammonium salt impurity, the glimepiride states uygur [...] ammonium salt the chemical name of the impurity (S)- 2 - (2 - carbamino pyrrolidine - 1 - yl) - N, N, N - triethyl - 2 - oxo ethyl ammonium chloride. The present invention provides a kind of new uygur geleg [...] ammonium salt impurity, the impurity in the existing literature has not been reported in, for vigelegting research further provides reference and conditions; the invention new uygur geleg [...] ammonium salt impurities of the preparation method is convenient, and the resulting high yield and purity, purity can be up to 98.7%, yield can reach 81.6%.
Vildagliptin related substance and preparation method thereof
-
Paragraph 0064; 0065; 0066; 0067; 0068; 0085-0089, (2019/06/12)
The invention provides a preparation method of a vildagliptin related substance. The preparation method comprises the following steps: (1) performing hydrolysis reaction on a compound I under a basiccondition to form a compound II; (2) enabling the compound II to react with chloroacetyl chloride to form a compound III as shown in the specification; (3) dehydrating the compound III and trifluoroacetic anhydride (TFAA) to form a compound IV as shown in the specification; (4) enabling the compound IV to react with 3-amino-1-adamantanol to form a compound V as shown in the specification. The synthesis method of the vildagliptin related substance, provided by the invention, is simple in steps, mild in reaction conditions and high in operability, and the related substance meeting the quality requirements can be obtained by simple purification; the preparation method is of great significance for drug development.
Preparation method of vildagliptin intermediate
-
Paragraph 0019; 0025-0036, (2020/01/08)
Belonging to the technical field of heterocyclic compounds, the invention provides a preparation method of a vildagliptin intermediate. The preparation method includes: adding prolinamide into a solvent, performing stirring and heating to dissolve prolinamide; performing cooling, adding propylene oxide as an acid-binding agent, and adding chloroacetyl chloride dropwise under stirring; carrying outcondensation reaction at the end of adding; lowering the temperature and performing heat preservation; conducting filtering, washing the filter residue, and performing drying to obtain (S)-1-(2-chloracetyl)pyrrolidine-2-amide. The method has the advantages of simple process, mild reaction conditions, high product purity and the like.
Acceptor-Controlled Transfer Dehydration of Amides to Nitriles
Okabe, Hiroyuki,Naraoka, Asuka,Isogawa, Takahiro,Oishi, Shunsuke,Naka, Hiroshi
supporting information, p. 4767 - 4770 (2019/06/17)
Palladium-catalyzed dehydration of primary amides to nitriles efficiently proceeds under mild, aqueous conditions via the use of dichloroacetonitrile as a water acceptor. A key to the design of this transfer dehydration catalysis is the identification of an efficient water acceptor, dichloroacetonitrile, that preferentially reacts with amides over other polar functional groups with the aid of the Pd catalyst and makes the desired scheme exergonic, thereby driving the dehydration.
Preparation method of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile
-
Paragraph 0050-0052; 0061-0063; 0071-0073, (2019/12/25)
The invention relates to the technical field of medicines, and especially relates to a preparation method of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile. The preparation method least comprises the following steps: L-prolinamide, an acid-binding agent and chloroacetyl chloride are respectively dissolved in a solvent to prepare a material A, a material B and a material C, the material A, the material B and the material C are respectively introduced into a micro-channel reactor and are reacted, a first reaction solution is collected, and undergoes liquid separation, and the obtained upper organic phase is collected; and the upper organic phase and thionyl chloride are respectively introduced into the micro-channel reactor, and are reacted, and a second reaction solution is collected, andis post-treated to obtain the (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile. The micro-channel reactor is used as a reaction container in the invention, so rapid proceeding of the reactions of ispromoted, side reactions are inhibited, the reaction efficiency is improved, and the production cost is greatly reduced.
Preparation method of vildagliptin intermediate
-
Paragraph 0049-0064, (2018/03/25)
The invention relates to a preparation method of a vildagliptin intermediate. The preparation method comprises the following steps: step 1, dissolving L-prolinamide in a heated organic solvent; step 2, adding chloroacetyl chloride for reaction; and step 3, after the reaction is finished, carrying out filtering, carrying out drip washing on the obtained solid by using the organic solvent in the step 1, and carrying out drying to obtain (S)-1-(2-chloroacetyl)-2-pyrrolidine carboxamide hydrochloride.
Vildagliptin impurity compound and preparation method thereof, detection method and application
-
Paragraph 0091-0093; 0130; 0133, (2018/11/04)
The invention relates to a Vildagliptin impurity compound and a preparation method thereof, a detection method and application. The Vildagliptin impurity compound has a structure as shown in the formula (I), wherein R1 is polyhalogenated C1-C4 lower alkyl or CH2R3, and R3 is five-membered/six-membered heterocyclic radical containing an N atom. The heterocyclic radical can be optionally replaced with CN or CONH2. The compound, as a reference substance or standard substance of related substances, can be used in quality control of a Vildagliptin preparation.
Synthesis and evaluation of camphor and cytisine-based cyanopyrrolidines as DPP-IV inhibitors for the treatment of type 2 diabetes mellitus
Kuranov,Tsypysheva,Khvostov,Zainullina, Liana F.,Borisevich,Vakhitova, Yu.V.,Luzina,Salakhutdinov
, p. 4402 - 4409 (2018/07/30)
In this study, bornyl- and cytisine-based cyanopyrrolidines as potent dipeptidyl peptidase-IV (DPP-IV) inhibitors were synthesised. The in vitro inhibiting activities of bornyl- and cytisine derivatives towards DPP-IV were evaluated. Bornyl-based cyanopyrrolidines were shown to have moderate inhibitory activity with regard to DPP-IV (1.27–15.78 μM). A docking study was performed to elucidate the structure-activity relationship of the obtained compounds. The in vivo hypoglycemic activities of the same compounds were evaluated with the oral glucose tolerance test (OGTT) in mice. Bornyl-based cyanopyrrolidines were shown to have good hypoglycemic activity.

